1妥匹坦帕洛諾司瓊膠囊(奧康澤®)說明書2021年9月2日版. 2Navari RM and Aapro M. N Engl J Med 2016;374:1356-67. 3Thomas AG et al. Exp Brain Res. 2014 Aug;232(8):2637-44. 4Zhang L, et al. Ann Oncol. 2018;29(2):452-458. 5中國臨床腫瘤學(xué)會(huì)(CSCO)抗腫瘤治療相關(guān)惡心嘔吐預(yù)防及治療指南(2019). 6NCCN clinical practice guidelines in oncology, Antiemesis V1,2019. 7Roila F, et al. Ann Oncol. 2016; 27(suppl 5): v119-v133. 8Hesketh PJ, et al. J Clin Oncol. 2017; 35(28): 3240-3261. 9中國藥學(xué)會(huì)醫(yī)院藥學(xué)專業(yè)委員會(huì). 中國醫(yī)院藥學(xué)雜志. 2022;42(5):457-473. 10中華醫(yī)學(xué)雜志 2022;102(39):3080-3094. 11Sun Y, et al. J Cancer Res Clin Oncol. 2021 Sep;147(9):2701-2708. 12Schwartzberg L,et al.Support Care Cancer. 2014 Feb;22(2):469-77. 13Molassiotis A, et al. J Pain Symptom Manage. 2016, 51(6) 987-993. 14Kim HK, et al. Support Care Cancer. 2015;23(1):293-300. 15Rojas C et Slusher BS. Eur J Pharmacol. 2012 Jun 5;684(1-3):1-7. 16Rojas C, et al. Eur J Pharmacol. 2010 Jan 25;626(2-3):193-9. 17Rojas C et al.J Pharmacol Exp Ther.2010 Nov;335(2):362-8. 18Stathis M et al. Eur J Pharmacol. 2012 Aug 15;689(1-3):25-30. 19Thomas AG et al. Exp Brain Res. 2014 Aug;232(8):2637-44. 20Lorusso V. Ther Clin Risk Manag. 2016 Jun 7;12:917-25. 21L Zhang, et al. Ann Oncol, 2018,29(2), 452-458. 22Park SH, et al. J Med Econ 2019;22:840-7. 23Restelli U, et al. BMJ Open. 2017,7(7):e015645. 24董涼涼, 等. 中國現(xiàn)代應(yīng)用藥學(xué). 2022;39(17): 2257-61. 25Lorusso V. Ther Clin Risk Manag. 2016 Jun 7;12: 917-25. |